Neutralization of Enterovirus D68 isolated from the 2014 US outbreak by commercial intravenous immune globulin products

Highlights • Developed an Enterovirus D68 (EV-D68)-specific microneutralization assay. • Detected high neutralizing antibody titers in intravenous immune globulin products. • Alignment of proposed antigenic sites may explain differences in titers. • Suggests possible effective treatment for primary...

Full description

Saved in:
Bibliographic Details
Published inJournal of clinical virology Vol. 69; pp. 172 - 175
Main Authors Zhang, Yiting, Moore, Deborah D, Nix, W. Allan, Oberste, M. Steven, Weldon, William C
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.08.2015
Subjects
Allergy and Immunology
Antibodies, Neutralizing - analysis
Antibody titers
Capsid - immunology
Disease Outbreaks
Enterovirus
Enterovirus D, Human - immunology
Enterovirus D68
Enterovirus Infections - therapy
Humans
Immunoglobulins, Intravenous - administration & dosage
Immunoglobulins, Intravenous - analysis
Immunologic Factors - administration & dosage
Immunologic Factors - analysis
Infectious Disease
Intravenous immunoglobulin
United States - epidemiology
United States
Antibody titers
Intravenous immunoglobulin
Enterovirus D68
Online AccessGet full text

Cover

More Information
Summary:Highlights • Developed an Enterovirus D68 (EV-D68)-specific microneutralization assay. • Detected high neutralizing antibody titers in intravenous immune globulin products. • Alignment of proposed antigenic sites may explain differences in titers. • Suggests possible effective treatment for primary antibody-deficient patients.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1386-6532
1873-5967
DOI:10.1016/j.jcv.2015.06.086